共 879 条
[1]
Abd El-Aziz TM(2020)Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID-19 Signal Transduc. Target Therapy 5 258-258
[2]
Al-Sabi A(2020)Comparative review of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza a respiratory viruses Front. Immunol. 11 552909-552909
[3]
Stockand JD(2021)Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections J. Adv. Res. 30 133-145
[4]
Abdelrahman Z(2020)Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue Eur. Respir. J. 56 270-699
[5]
Li M(2020)Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety J. Drug Target. 28 683-919
[6]
Wang X(2021)A comprehensive review on Covid-19 Delta variant Int. J. Pharmacol. Clin. Res. 5 7-631
[7]
Abu-Izneid T(2021)COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection Eur. J. Clin. Microbiol. Infect. Dis. 40 905-12
[8]
AlHajri N(2020)Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): immunoinformatics approach J. Med. Virol. 92 618-6646
[9]
Ibrahim AM(2021)Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator Acta Pharmac. Sin. B 11 1-23
[10]
Javed MN(2004)Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice Proc. Natl. Acad. Sci. 101 6641-4